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Abstract
The optimal markers for human spermatogonial stem cells (SSCs) are not known. Among the 
genes recently linked to SSCs in mice and other animals are the basic helix-loop-helix 
transcription factor ID4 and the orphan G-protein coupled receptor GPR125. While ID4 and 
GPR125 are considered putative markers for SSCs, they have not been evaluated for co-
expression in human tissue. Further, neither the size nor the character of the human 
spermatogonial populations that express ID4 and GPR125, respectively, are known. A major 
barrier to addressing these questions is the availability of healthy adult testis tissue from donors 
with no known reproductive health problems. To overcome this obstacle, we have employed 
healthy testicular tissue from a novel set of organ donors (n=16; aged 17-68 years) who were 
undergoing post-mortem clinical organ procurement. Using immunolabeling, we found that ID4 
and GPR125 are expressed on partially overlapping spermatogonial populations and are more 
broadly expressed in the normal adult human testis. Additionally, we found that expression of ID4 
remained stable during aging. These findings suggest that ID4 and GPR125 could be efficacious 
for identifying previously unrecognized human spermatogonial subpopulations in conjunction 
with other putative human stem cell markers, both in younger and older donors.
Introduction
Adult male germline stem cells, referred to as spermatogonial stem cells (SSCs), comprise a 
small population within the mammalian testis (de Rooij and Griswold, 2012; Dym, et al., 
2009). While the actual size of the SSC population is a matter of debate, fertility is 
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maintained into advanced age in most healthy males. The ability to maintain homeostatic 
organ function implies an exquisitely robust self-renewal system that can withstand 
environmental challenges. SSCs are typically considered to be isolated type A 
spermatogonia (SPG), referred to as Asingle or As; these can differentiate into committed 
progenitors to produce syncitia of paired cells (Apr) or larger chains of cells (de Rooij and 
Griswold, 2012). However, classical morphological features (e.g., nuclear morphology, or 
single cells vs. chains) have been challenging to correlate with newer molecular markers 
(von Kopylow, et al., 2012).
Compared to SSCs in animals, human SPG, including SSCs and committed progenitors, 
present unique challenges to study due to limited availability of normal tissue and a paucity 
of experimental assays. Chromatin structure was used historically to classify human SPG as 
Adark or Apale, but the functional significance of such differences has been controversial 
(Dym, et al., 2009; Ehmcke and Schlatt, 2006; Hermann, et al., 2010). Recently, 
comparisons between cellular morphology and expression of molecular markers have 
revealed surprising degree of diversity within human type A SPG (Lim, et al., 2011; von 
Kopylow, et al., 2012). Furthermore, only a small number of markers are available to 
delineate the cell populations encompassing human SPG or SSCs, respectively (Waheeb and 
Hofmann, 2011). Xenotransplantation has been developed to assess SSC activity in human 
testicular cells (Nagano, et al., 2002; Zohni, et al., 2012). However, it remains quite unclear 
what fraction of germ cells in the adult human testis are SSCs.
As a basis for developing effective functional assays, two essential preliminary components 
for studying human SSCs and committed progenitors include the ability to enrich the target 
cell population using immunoselection and to be able to confirm that the selected cells are 
phenotypically pure SPG or, more specifically, enriched for true SSCs. Toward this end, a 
plethora of markers, either with internal or cell surface expression, have been developed for 
SSCs in model systems, such as the mouse; surface markers include Thy1, Itga6, CD9, 
Gfra1, and others (Nagano and Yeh, 2013). In humans, proposed SSC markers include CD9, 
GPR125, SSEA-4, ITGA6 (He, et al., 2010; Izadyar, et al., 2011; Zohni, et al., 2012). Only 
CD9 and SSEA-4 have been evaluated by xenotransplantation (Izadyar, et al., 2011; Zohni, 
et al., 2012). GPR125 was discovered by recognition of an expression pattern in the adult 
mouse testis consistent with that of SPG, including SSCs (Seandel, et al., 2007). More 
recently GPR125 was employed for immunoselection of human testicular cells (He, et al., 
2010). In the latter study, a very small fraction of SPG (~1-2 cells per tubular cross section) 
was positive for GPR125 expression. GPR125 expression is also detectable in long-term 
pre-pubertal testicular cell cultures that contain SSCs (Sadri-Ardekani, et al., 2011). It is not 
known whether adult GPR125+ testicular cells have functional stem cell activity in vivo.
Among intracellular markers, PLZF has been used effectively both in mice and in primates 
to identify undifferentiated SPG (He, et al., 2010; Hermann, et al., 2007; Hobbs, et al., 
2010). UTF1 (undifferentiated embryonic cell transcription factor 1) is a pluripotency-
associated gene that also clearly marks SPG in the adult human testis (Kristensen, et al., 
2008; von Kopylow, et al., 2010). Id4 is a member of the basic helix-loop-helix transcription 
factor family (Benezra, et al., 1990; Yokota, 2001). Previously, ID4 expression was 
demonstrated in SPG in human testicular tumors (Sablitzky, et al., 1998). Recently, Id4 was 
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shown not only to mark type Asingle SPG in mice but also to be required for SSC self-
renewal in vitro and to prevent the Sertoli cell-only phenotype in vivo (Oatley, et al., 2011). 
These findings raise the questions of whether ID4 expression could mark SSCs in the 
normal adult human testis and to what extent different subpopulations of SPG share ID4 
expression.
Typical sources of human testis tissue for adult SSC studies include men with infertility, 
cancer patients, and cadaveric organ donors, across a range of ages, depending on 
availability. Cadaveric organ donors represent a particularly attractive source of viable adult 
testis tissue, since other donor organs (e.g., heart, lungs, kidneys, and/or liver) are healthy 
enough for transplant into patients (He, et al., 2010). While most healthy men maintain 
fertility into advanced age, hypospermatogenesis is not uncommon in testicular biopsies 
(McLachlan, et al., 2007). Therefore, it is important to determine how much age-related 
variation exists in expression of candidate SPG markers. In this study, we sought to evaluate 
several recently identified candidate human SPG markers in normal adult testis tissue from 
cadaveric organ donors. We hypothesized that ID4 and GPR125, respectively, would mark 
very small populations of type A SPG in normal adults. We found large numbers of ID4+ 
SPG in adult human testis (n=16, age range = 17-67 years) in all seminiferous tubules from 
all donors. ID4 expression partially overlapped with UTF1, a well-documented human SPG 
marker (Kristensen, et al., 2008). ID4 expression also overlapped partially with GPR125, 
which itself was expressed on a larger number of cells per tubule than expected. No age-
related changes in expression of ID4 or GPR125 in SPG were seen in this sample set.
Materials and Methods
Tissue procurement
Testes were obtained from deceased organ donors through collaboration with the New York 
Organ Donor Network after specific consent was obtained from next of kin. All available 
donors suitable for clinical organ transplantation during the study period were considered 
eligible for the research study irrespective of past medical history, except those with known 
HIV or hepatitis C. All human tissue procurement procedures were conducted in accordance 
with Weill Cornell Medical College guidelines and National Institutes of Health regulations. 
The data in this study were obtained from 16 donors (17 to 67 years old). The causes of 
death included cerebrovascular accident, homicide, suicide, cardiac death, and trauma. 
Following resection of other viable organs for clinical transplantation, a bilateral 
orchiectomy was performed. Time from cross-clamp of the aorta to orchiectomy ranged 
from 70 to 135 minutes. Immediately following orchiectomy, tissue was transported to the 
laboratory packed in ice. Each human testis sample was dissected on top of an ice bath into 
~0.5-1.5 cm3 tissue fragments and immediately allocated for different procedures. 
Fragments were snap frozen in liquid nitrogen for subsequent mRNA analysis. Additional 
fragments were fixed by immersion in •10-fold excess by volume of 4% paraformaldehyde 
(PFA) in PBS or in Bouin's fixative at 4° C for 8-16 hours. Samples were washed and later 
processed for paraffin embedding. Tissue integrity was subsequently confirmed by routine 
histopathological evaluation (see below).
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Bouin's fixed tissue was employed for immunohistochemistry (IHC) and 
immunofluorescence (IF) except as specifically noted otherwise. Five micron sections were 
warmed for 30 minutes at 60° C, de-waxed in xylene and rehydrated through a series of 
graded alcohols. After deparaffinization, antigen retrieval was performed by heat-induced 
epitope retrieval in an electric steamer using Tris-EDTA antigen retrieval buffer (pH 9) for 
15-45 minutes. Hydrogen peroxide (3%) was used to block endogenous peroxidase activity. 
After blocking with either 10% normal donkey serum or tyramide signal amplification 
buffer (1% BSA, 0.2% powdered skim milk, 0.3% Triton X-100), sections were treated with 
Avidin/Biotin Blocking Kit (Vector Laboratories, SP-2001) to block all endogenous biotin, 
biotin receptors, and avidin binding sites. Sections were then incubated with primary 
antibodies at optimal dilutions (as listed in Table 1) overnight at 4° C. For IHC, detection of 
primary antibodies was performed with biotinylated donkey anti-rabbit IgG, biotinylated 
donkey anti-mouse IgG, or biotinylated donkey anti-goat (all from Jackson 
Immunoresearch) at a concentration of 1 μg/mL. Biotinylated secondary antibody was 
followed by streptavidin-horseradish peroxidase conjugate (Jackson Immunoresearch) and 
amino-ethyl carbazole (AEC; Life Technologies). Specificity of immunostaining was 
confirmed by staining with the immunoglobulin fraction of the species corresponding to the 
primary antibody. Color images of IHC staining were captured using an Olympus 
microscope and Spot camera and contrast enhanced uniformly for all images within each 
experiment using ImageJ (Schneider, et al., 2012). For KIT and WT1, 5 micron thick 
paraffin-embedded tissue sections were stained using the BOND III Autostainer and 
supplied reagents (Leica Microsystems, Buffalo Grove, IL, USA).
For IF detection of ID4, Ki76, and UTF1, Alexa Fluor® 488-conjugated goat anti-rabbit IgG 
(Jackson Immunoresearch) and Cy3-conjugated donkey anti-mouse (Jackson 
Immunoresearch) or Alex Fluor® 488-conjugated anti-mouse secondary antibodies were 
used respectively. GPR125, and PLZF were detected using signal amplification with biotinyl 
tyramide (Jacobs, et al., 1998). Following overnight incubation with the primary antibody, 
sections were incubated for 90 minutes with biotinylated donkey anti-mouse IgG and 
biotinylated donkey anti-goat (Jackson Immunoresearch) respectively at a concentration of 1 
μg/mL. Following incubation with the biotinylated secondary antibody, sections were 
incubated subsequently with streptavidin-horseradish peroxidase conjugate (Jackson 
Immunoresearch) for 30 minutes and biotinyl tyramide for 3-20 minutes. Incubation with 
biotinyl tyramide was followed by a 30-minute incubation with a streptavidin-conjugated 
fluorophore (as listed in Table S1). Counterstaining was performed with TO-PRO®-3 iodide 
(Life Technologies). Specificity of staining was again confirmed by staining with the 
corresponding normal immunoglobulin. Lack of cross-reactivity in co-staining protocols 
was confirmed by incubation with a single primary antibody followed by the detection 
system for the second antibody (data not shown). For example, the rabbit ID4 antibody was 
treated with the anti-goat and anti-mouse detection systems in order to ensure that there was 
no cross-reactivity. Fluorescent images were captured using Zeiss LSM 510 Meta and 710 
confocal microscopes (Carl Zeiss). For each channel, signal was enhanced uniformly for all 
fields within each experiment using the LSM or ImageJ software. While occasional non-
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specific reactivity was seen interstitial areas or in the tubule lumen, species matched controls 
for primary and secondary antibodies yielded little signal (Supplemental Fig. S1).
Quantification of spermatogonial markers and statistical analysis
Length of outer border of the tubular cross section was measured by tracing the tubule 
perimeter free hand in ImageJ and using the software to measure the perimeter length in 
relative units (Supplemental Fig. S2). Positively marked cells were determined in 
comparison with normal rabbit IgG controls. Captured images were contrast-enhanced 
uniformly for each experiment and thresholded in ImageJ prior to counting which was done 
in a blinded fashion by two independent observers. Those cells around the basement 
membrane of the seminiferous tubule, which displayed a strong stain, were counted as 
positive. Positively stained cells in the interstitium or located adluminal to the basement 
membrane within the tubule were not counted. For serial sections, only cells that could be 
unequivocally identified (based on counterstain and location) in both sections were counted. 
The average number of cells per unit length was calculated from four random fields per 
patient. To avoid introducing bias due to known azoospermia, the single patient with 
complete maturation arrest was omitted from the statistical analysis of ID4. Cell number 
data were analyzed using the Mann-Whitney test for non-parametric data (GraphPad Prism 
6).
Results
Pathological evaluation of cadaveric human testis samples
Testis samples were procured from cadaveric organ donors (n=16), ages 17 to 67, after 
specific consent was obtained from the next of kin (Table 2). All potential donors were 
included except as noted above (see Methods). Testis histology was evaluated using H&E 
staining of Bouin's or paraformaldehyde-fixed, paraffin-embedded tissue samples. With a 
single exception, all donors exhibited spermatogenesis (Fig. 1). One donor had germ cells 
arrested at the SPG stage. Five other donors (all age •42) had occasional tubular atrophy 
had occasional tubular atrophy or hypospermatogenesis to varying degrees but were 
otherwise unremarkable (Table 2).
ID4 is expressed in a subpopulation of spermatogonia in normal human testis
Detection of ID4 by either IF or IHC demonstrated consistent strong anti-ID4 reactivity 
localized either to the nucleus alone or more commonly to both the cytoplasm and nucleus 
of a subpopulation of SPG found immediately adjacent to the basement membrane of the 
seminiferous tubule (Fig. 2). More differentiated germ cell types were negative. Sertoli cells, 
identifiable based on expression of WT1, stained weakly or negative for ID4 (Mundlos, et 
al., 1993)(Supplemental Fig. S7). IgG controls for the primary antibody yielded no signal 
(data not shown). Of note, specificity of the anti-ID4 clone 82-12, which lacks cross-
reactivity to human ID1, ID2, and ID3, was confirmed by a similar expression pattern found 
in normal human testis in the Human Protein Atlas, using a different primary antibody 
(Sharma, et al., 2012; Uhlen, et al., 2010; Wen, et al., 2012).
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Germ cell chromatin structure, specifically the presence or absence of a nuclear rarefaction 
zone, has been used previously to classify human SPG and can distinguish the Adark and the 
Apale SPG subtypes (Clermont, 1966; von Kopylow, et al., 2012). Accordingly, DNA 
counterstaining confirmed that the ID4-positive cells included cells with a clearly 
recognizable nuclear rarefaction zone and also those without (Fig. 2). Based on the location 
of the population intensely expressing ID4, which was restricted to the cells lining the 
basement membrane, in conjunction with the nuclear morphology, it is likely that these cells 
include type A SPG.
In order to determine whether the number of ID4+ cells changes with age within the limits of 
the available samples, we quantified the number of ID4+ cells in each donor and arbitrarily 
subdivided the available specimens into age brackets comprising younger (17-25 years; n=4) 
vs. older (42-67 years; n=12) donors. Since human seminiferous tubule cross sections are of 
irregular shape, we determined the number of ID4+ cells per unit length of tubule and found 
no significant difference based on age brackets (Mann-Whitney U-test, p > 0.05), with an 
average of ~17 ID4+ cells per transverse (i.e., circular) tubule cross-section in the entire set 
(Fig. 2). Thus, normal aging appeared to have no effect on the frequency of SPG that exhibit 
strong ID4 expression.
Overlap in expression of ID4 and markers of spermatogonia
To further characterize the ID4-expressing SPG, immunostaining was performed for ID4 
and additional markers of spermatogonia. As a surrogate marker for differentiating 
spermatogonia, KIT was co-localized at the cellular level with ID4 using IHC on serial thin 
sections (Supplemental Fig. S7). The KIT+ fraction was a minor population of the ID4+ 
germ cell pool (13.3±4.1% [mean±S.D.], Table S2). In contrast, PLZF was employed as a 
marker of undifferentiated spermatogonia (Buaas, et al., 2004; Hermann, et al., 2007). 
Consistent with the expected pattern based on prior studies (von Kopylow, et al., 2012), 
PLZF expression was restricted to the nuclei of SPG adjacent to the basement membrane of 
the seminiferous tubules (Fig. 3). Co-labeling with anti-ID4 and anti-PLZF revealed that the 
vast majority of ID4-positive cells co-expressed PLZF (96.1±1.8% [mean±S.D.]; Table S2). 
Negative controls (normal, species-matched IgG) showed little or no signal along the 
basement membrane (Supplemental Fig. S1).
To confirm that ID4 is expressed relatively broadly across subsets of SPG, we selected 
UTF1 as a well-defined SPG marker. UTF1 expression was consistent with previously 
documented antibody specificities and was localized to the nuclei of SPG immediately 
adjacent to the basement membrane of the seminiferous tubules (Fig. 4; Supplemental Fig. 
S3) (Kristensen, et al., 2008). There was no discernible age-related change in the number of 
UTF1-positive cells (Supplemental Fig. S3 and data not shown). The co-expression pattern 
of ID4 and UTF1 revealed both UTF1-positive and UTF1-negative cells among the ID4+ 
SPG (Fig. 4; Supplemental Fig. S4; Table S2). The ID4+/UTF1+ SPG constituted 
approximately 37.1±15.1% (mean±S.D.) of ID4-positive cells. Therefore, ID4 and UTF1 
mark distinct but partially overlapping subpopulations of SPG. In conjunction with the 
results for PLZF, these data indicate that the ID4+ population encompasses a broad spectrum 
of human SPG, including the undifferentiated subset.
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ID4-expressing cells tend to be rarely dividing
To determine whether the ID4+ SPG population is part of the mitotically-active cell fraction 
in the seminiferous tubule, Ki67 staining was employed. Co-labeling for ID4 and Ki67 
revealed expression in generally non-overlapping germ cell populations, with only 0.6-2.8% 
of ID4-expressing cells co-stained for Ki67 (Fig. 5; Table S2). While the aforementioned 
ID4+ population was located in the monolayer along the basement membrane of the 
seminiferous epithelium, the Ki67+ population extended toward the adluminal zone of the 
tubule. This population comprised an irregular distribution of cell clusters, consistent with 
the expected appearance of type B SPG. These data indicate that the majority of the ID4+ 
population is rarely dividing.
The ID4-positive spermatogonial population overlaps substantially with GPR125-
expressing germ cells
GPR125 marks undifferentiated SPG in mice and has been employed for selection of 
putative SSCs in humans (He, et al., 2010; Seandel, et al., 2007). Using an amplified 
detection system for enhanced sensitivity, we found that GPR125 is expressed in a 
comparatively large subpopulation of germ cells residing along the basement membrane of 
the seminiferous tubule but not in Sertoli cells, consistent with the reported GPR125 
expression pattern in the adult mouse testis (Fig. 6 and Supplemental Fig. S5). Of note, 
GPR125 signal intensity varied widely both between patients and within patients, possibly 
due to slight differences in tissue fixation of labile, low abundance antigens. GPR125 was 
only detectable in Bouin's-fixed tissue but not in paraformaldehyde-fixed tissue. In each 
field that could be evaluated, •5 cells expressed GPR125. Co-staining for ID4 and GPR125 
revealed substantial but not complete overlap between the ID4+ and GPR125+ SPG 
populations, respectively, along the basement membrane of both younger and older donors, 
although variations in signal intensity precluded reliable counting of GPR125+ cells (Fig. 6; 
Supplemental Fig. S6).
Discussion
The ideal stem cell marker is both highly sensitive and specific, and such features are critical 
not only for uncovering the molecular mechanisms of stem cell control but also for 
implementing clinical stem cell-based protocols safely (e.g., for exclusion of contaminants). 
To date, a relatively small array of candidate stem cell markers have been evaluated in 
normal adult human testis tissue, whereas a larger array of studies employed tissue from 
patients with azoospermia or other disorders. Herein, we have confirmed that expression of 
candidate SSC markers ID4 and GPR125 is maintained in SPG within the normal adult 
human testis into the seventh decade of life but that ID4+ and GPR125+ cells represent a 
larger fraction of SPG than expected based on prior work.
Expression of basic helix-loop-helix transcription factors of the ID family has been found in 
conjunction with a variety of stem types (Yokota, 2001). Based on firm genetic data linking 
ID4 expression to the SSC phenotype in mice, we sought to evaluate ID4 in normal adult 
human testis (Oatley, et al., 2011). Previously, it was shown that type A SPG contained 
within human testicular seminomatous tumors express ID4 in the cytoplasm, but normal, 
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non-malignant tissue has not been studied (Sablitzky, et al., 1998). We found both nuclear 
and cytoplasmic expression of ID4 in the normal testis, irrespective of donor age. The 
biological significance of the nuclear-to-cytoplasmic ratio of ID4 in SPG is unknown but 
could represent the effect of a dynamic signal rather than a marker for cellular 
differentiation status. Our data suggest that the distribution of ID4 positive cells in humans 
may be generally less restricted than in rodents (Oatley, et al., 2011).
In contrast to the sparse distribution of ID4+ type Asingle SPG in the murine testis (Oatley, et 
al., 2011), we found large numbers of strongly-positive cells in the human testis by 
immunostaining using a highly specific monoclonal antibody for ID4. In conjunction with 
the prior findings of Sablitzky et al. (1998), the expression pattern that we observed, 
consistent with the pattern observed with another unrelated antibody, is likely to represent 
authentic ID4 protein (Sablitzky, et al., 1998; Uhlen, et al., 2010). One interpretation of the 
unexpectedly large pool of ID4 positive SPG in humans is that expression is not restricted to 
stem cells but this would need to be validated using functional assays.
GPR125 is an orphan G-protein coupled receptor that marks a large pool of murine 
undifferentiated SPG including SSCs (Seandel, et al., 2007). The implementation of 
GPR125 for cell sorting, prospective validation of putative human SSCs, or immunostaining 
has been hampered by the lack of quality antibodies and inconsistent results (von Kopylow, 
et al., 2012). Our data are consistent with a similar pattern of GPR125 expression in the 
human testis as was seen in mice, with GPR125+ cells in a more broad distribution than 
would be expected for SSCs alone. Whereas He et al. (2010) found the immunoreactivity of 
GPR125 to be limited to 1-2 cells per seminiferous tubule cross-section (He, et al., 2010), 
we confirmed the existence of GPR125+ cells in a similar distribution but at a higher 
frequency (•5 cells) in transverse sections through the tubules using a different antibody. 
This difference could be due to the highly sensitive immunodetection system that we 
employed.
While the function of GPR125 remains enigmatic, anti-GPR125 antibodies have been 
employed for immunoselection of human SSCs (He, et al., 2010). Various studies have 
successfully detected GPR125 at the mRNA level, but mixed results have been obtained in 
analysis of GPR125 protein (von Kopylow, et al., 2012). In fact, we tested multiple 
commercial human anti-GPR125 antibodies that yielded non-specific staining in the human 
testis (data not shown) before finding effective ones. We speculate that low levels of 
GPR125 antigen density and/or stability necessitate a highly amplified detection system 
when employing available commercial anti-GPR125 antibodies (e.g., from Novus 
Biologicals), given that GPR125 antigen(s) were generally only detectable in Bouin's fixed 
tissue but not after paraformaldehyde fixation.
The common expression of ID4 and UTF1, PLZF, or GPR125 in some but not all SPG 
suggests that substantial heterogeneity exists within the undifferentiated SPG. However, 
given the limitations of archived samples, it is difficult to ascertain whether expression of 
such markers is stable or varies in a dynamic fashion, related to the status of the cell and 
surrounding microenvironment. For example, GPR125 expression in mice varied 
substantially with the stage of the spermatogenic cycle of the seminiferous tubules but it is 
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presently unclear whether or not the same is true in humans (Seandel, et al., 2007). 
Interestingly, ID4+ cells did not tend to include the Ki67+ fraction, presumed to be 
proliferating cells. However, it is unknown what fraction of authentic human SSCs are likely 
to be mitotically actively vs. quiescent.
Whereas most human gametes yield healthy offspring, subtle yet pathogenic alterations can 
occur in a cell autonomous or non-cell autonomous manner with aging of men (Paul and 
Robaire, 2013). We did not detect substantial age-related changes in the populations of SPG 
labeled by the candidate markers in this study, although the sample size is small. This result 
is generally consistent with conclusions obtained using morphological criteria to identify 
Adark and Apale SPG which do not decrease substantially until after about the sixth decade 
(Nistal, et al., 1987). Furthermore, potential age-related declines in spermatogenic function 
are unlikely to be constrained by the size of the ID4+ population. Finally, the absence of 
substantial age-related changes in the Type A SPG populations indicates that cadaveric 
organ donor tissue even from older adults is useful for further studies of undifferentiated 
SPG and possibly SSCs.
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Histology of adult cadaveric organ donor testes of varying ages. Hematoxylin and eosin 
staining of Bouin's fixed tissue: (A) 22 year old, (B) 43 year old, and (C) 62 year old, 
demonstrating excellent tissue preservation as well as active spermatogenesis with complete 
maturation.
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ID4 expression in normal testis from early through later adulthood. (A-C) IF demonstrating 
rabbit monoclonal anti-ID4 signal (green; panel A), DNA counterstain alone (blue; panel B), 
or merged image (C). Arrows denote ID4+ cells with nuclear rarefaction zones, seen as dark 
areas within the nucleus in the inset. Arrowhead denotes a cell without a nuclear rarefaction 
zone. Bar is 50 μm. (D-E) Representative ID4+ IHC (reddish-brown) on PFA-fixed tissue in 
a 21 year old (D) and 49 year old (E). (F) Quantification of ID4+ cells in PFA-fixed samples 
grouped by age (Mann-Whitney U-test, p >0.05)
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Co-localization of anti-ID4 and anti-PLZF signals in the human seminiferous epithelium. 
Representative IF using rabbit monoclonal anti-ID4 (green; A) or mouse monoclonal anti-
PLZF (red; B), DNA counterstain (blue; C), or merged image (D) from a 21 year old. 
Arrows denote ID4+/PLZF+ cells. Bar is 50 μm. Insets show selected ID4+/PLZF+ cells with 
both cytoplasmic and nuclear staining.
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Co-localization of anti-ID4 and anti-UTF1 signals in the human seminiferous epithelium. 
Representative IF using rabbit monoclonal anti-ID4 (green; A) or mouse monoclonal anti-
UTF1 (red; B), or merged image (C) from a 21 year old. Cell populations labeled: ID4+/
UTF1+ (arrows), ID4+/UTF1− (arrowheads), and ID4−/UTF1+ (asterisks). Bar is 50 μm.
Sachs et al. Page 15














The majority of ID4-positive in the human seminiferous epithelium are not mitotically-
active. Representative IF showing a small minority of anti-ID4 reactive cells (green) that co-
expressed Ki67 (red). DNA counterstain is (blue). (A) Merged image at low magnification. 
(B-D) Higher magnification views of the field denoted by dashed line in (A). (B) Ki67 (red). 
(C) ID4 (green). (D) Merged image. (Arrowheads denote ID4+/Ki67+ cells; Asterisks denote 
selected ID4+/Ki67− cells.) Bar is 25 μm.
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Partial overlap of anti-ID4 and anti-GPR125 signal in the human seminiferous epithelium. 
Representative IF using rabbit monoclonal anti-ID4 (green; A) or goat polyclonal anti-
GPR125 (red; B), DNA counterstain (blue; C), or merged image (D) from a 49 year old. Cell 
populations labeled: ID4+/GPR125+ (arrows), ID4-/low/GPR125+ (arrowheads), and ID4+/
GPR125− (asterisk). Bar is 50 μm.
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Table 1
Primary antibodies used in this study
Antigen Company Code Species Host Clonality Working Concentration
GPR125 Novus Biologicals NBP1-03561 Human Goat Polyclonal 0.4 μg/mL
ID4 Calbioreagents M106 Human/Mouse Rabbit Monoclonal (82-12) 5 μg/mL
UTF1 Chemicon (Millipore) MAB 4337 Human/Mouse Mouse Monoclonal (5G10.2) 5 μg/mL
Ki67 Dako M7240 Human Mouse Monoclonal (MIB-1) 0.1 μg /mL
KIT Dako A4502 Human Rabbit Polyclonal 26 μg/mL
WT1 Dako IS055 Human Mouse Monoclonal (6F-H2) Ready-to- use format
PLZF Santa Cruz Biotechnology SC-28319 Human/Mouse/Rat Mouse Monoclonal (D-9) 0.1 μg/mL
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Table 2
Demographic and histological summary of donors.




1 17 CVA None
2 21 CVA None
3 22 Suicide None
4 25 MVA None
5 42 CVA Tubular atrophy (5-10% of tubules)
6 43 CVA None
7 49 Cardiac arrest None
8 49 Cardiac arrest Marked hypospermatogenesis; tubular atrophy (10% of tubules)
9 51 CVA None
10 52 Homicide None
11 54 Cardiac arrest Complete maturation arrest (azoospermia), predominantly at the primary spermatocyte level; 
tubular atrophy (5% of tubules); moderate to marked diffuse basement membrane thickening
12 57 CVA None
13 62 CVA Mild hypospermatogenesis; mild diffuse basement membrane thickening
14 63 CVA None
15 67 CVA Tubular atrophy (5-10% of tubules); mild diffuse basement membrane thickening
16 67 MI Moderate hypospermatogenesis; tubular atrophy (10-20% of tubules); moderate diffuse basement 
membrane thickening
*
CVA, cerebrovascular accident; MVA, motor vehicle accident; MI, myocardial infarction.
**
Spermatogonia were observed in all samples. Samples with decreased spermatogenesis or other findings are specifically noted.
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